确定淋巴组织中的HIV和SIV储存库。
Defining HIV and SIV Reservoirs in Lymphoid Tissues.
作者信息
Deleage Claire, Wietgrefe Stephen W, Del Prete Gregory, Morcock David R, Hao Xing Pei, Piatak Michael, Bess Julian, Anderson Jodi L, Perkey Katherine E, Reilly Cavan, McCune Joseph M, Haase Ashley T, Lifson Jeffrey D, Schacker Timothy W, Estes Jacob D
机构信息
AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
Department of Microbiology and Immunology, Medical School, University of Minnesota, Minneapolis, MN 55455.
出版信息
Pathog Immun. 2016 Spring;1(1):68-106. doi: 10.20411/pai.v1i1.100.
A primary obstacle to an HIV-1 cure is long-lived viral reservoirs, which must be eliminated or greatly reduced. Cure strategies have largely focused on monitoring changes in T cell reservoirs in peripheral blood (PB), even though the lymphoid tissues (LT) are primary sites for viral persistence. To track and discriminate viral reservoirs within tissue compartments we developed a specific and sensitive next-generation hybridization approach to detect vRNA, including vRNA+ cells and viral particles ("RNAscope"), vDNA+ cells ("DNAscope") and combined vRNA and vDNA with immunohistochemistry to detect and phenotype active and latently infected cells in the same tissue section. RNAscope is highly sensitive with greater speed of analysis compared to traditional hybridization. The highly sensitive and specific DNAscope detected SIV/HIV vDNA+ cells, including duplexed detection of vDNA and vRNA or immunophenotypic markers in the same section. Analysis of LT samples from macaques prior to and during combination antiretroviral therapy demonstrated that B cell follicles are an important anatomical compartment for both latent and active viral persistence during treatment. These new tools should allow new insights into viral reservoir biology and evaluation of cure strategies.
实现人类免疫缺陷病毒1型(HIV-1)治愈的一个主要障碍是长期存在的病毒储存库,必须消除或大幅减少这些储存库。治愈策略主要集中在监测外周血(PB)中T细胞储存库的变化,尽管淋巴组织(LT)才是病毒持续存在的主要部位。为了追踪和区分组织隔室内的病毒储存库,我们开发了一种特异且灵敏的新一代杂交方法来检测病毒RNA(vRNA),包括vRNA+细胞和病毒颗粒(“RNAscope”)、vDNA+细胞(“DNAscope”),并将vRNA和vDNA与免疫组织化学相结合,以在同一组织切片中检测并鉴定活跃感染和潜伏感染的细胞。与传统杂交相比,RNAscope灵敏度高且分析速度更快。高度灵敏且特异的DNAscope检测到了猴免疫缺陷病毒/人类免疫缺陷病毒(SIV/HIV)vDNA+细胞,包括在同一切片中对vDNA和vRNA或免疫表型标志物的双重检测。对猕猴在联合抗逆转录病毒治疗之前和期间的LT样本分析表明,B细胞滤泡是治疗期间潜伏和活跃病毒持续存在的一个重要解剖隔室。这些新工具应能为病毒储存库生物学提供新的见解,并有助于评估治愈策略。